Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal epithelial cell surface constitutes the interface between the gut lumen and the body, providing a physical and functional barrier through tight junctions, specialized membrane proteins (such as transporters, enzymes, and receptors), and extracellular glycocalyx structures[1][4][2]. It is formed by a single layer of columnar IECs, including enterocytes, goblet cells, Paneth cells, and enteroendocrine cells[1][3]. The cell surface is highly dynamic, involved in nutrient absorption, secretion, protection from pathogens, and immune crosstalk[1][4][5]. Alterations or damage to the cell surface are associated with intestinal disorders including inflammatory bowel disease, infections, and cancer[2][5][6]. While numerous drugs and therapies target specific cell surface proteins of IECs, the "cell surface" itself is not a standard molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal epithelial cell surface.